Alto Neuroscience, Inc.
ANRO
$24.37+1.41%
End of day · as of Oct 10, 2026, 2:02 AM ET
Mkt cap
$60.10M
EV/Sales
N/A
P/E ratio
N/A
Revenue (FY2025)
N/A
EPS (H1 2026)
$-21.85
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
N/A
Beta
N/A
Div yield
N/A
Sector
Healthcare
Alto Neuroscience, Inc. (ANRO) is a biotechnology company listed on US.
Use this ANRO research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ANRO income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Alto Neuroscience, Inc. (ANRO) is a biotechnology company in the Healthcare sector.
Latest cached Alto Neuroscience, Inc. (ANRO) net income for FY2025 was -$63.2M. Statements: https://lician.com/financials/anro
Alto Neuroscience, Inc. (ANRO) market capitalization is $60.1M on the latest cached snapshot.
Alto Neuroscience, Inc. (ANRO) cached previous close $24.03; day range $23.81 – $25.11; volume 649,425. Session quote: https://lician.com/quote/anro
Alto Neuroscience, Inc. (ANRO) latest cached earnings event is "ANRO earnings" on Aug 12, 2026. Earnings calendar: https://lician.com/earnings
The latest cached ANRO filing is 8-K · Aug 27, 2026. Filings: https://lician.com/sec/anro